California latest to sue drug companies over insulin prices

Jan 12, 2023, 12:04 AM | Updated: 6:02 pm
California Attorney General Rob Bonta, middle, speaks at a news conference in Sacramento, Calif., o...

California Attorney General Rob Bonta, middle, speaks at a news conference in Sacramento, Calif., on Thursday, Jan. 12, 2023. Bonta announced a lawsuit accusing multiple companies that make or promote insulin of keeping prices too high. (AP photo/Adam Beam)

(AP photo/Adam Beam)

SACRAMENTO, Calif. (AP) — California on Thursday announced it will sue the companies that make and promote most of the nation’s insulin, accusing them of scheming to illegally increase the price of the drug and demanding they return millions of dollars to some diabetics who state officials say were overcharged for the medicine they must have to survive.

The lawsuit, to be filed in Los Angeles County Superior Court by Attorney General Rob Bonta, is the latest in a parade of legal actions against these companies from states across the political spectrum — all who have accused the corporate giants of abusing their power to quash competition and boost their profits by keeping the price of insulin high.

A 2021 study by the RAND Corporation comparing the insulin prices of nearly three dozen countries found prices in the United States were about 10 times higher than everywhere else. The average price of a vial of insulin in the United States was $98, while in nearby Canada it was $12.

Attorneys general in Kansas, Arkansas,Mississippi,Minnesota and Kentucky have all filed similar lawsuits in recent years.

“It is not a partisan issue,” said Bonta, a Democrat who was elected to his first full term in November. Bonta said state attorneys general from both major political parties “all say the same thing: That the status quo is unacceptable and problematic and awful.”

Bonta sued three companies who make insulin — Eli Lilly, Novo Nordisk, and Sanofi — and three companies who manage prescription drug programs that provide insulin — CVS Caremark, Express Scripts and Optum Rx.

Bonta said the manufacturers raise the price of insulin “in lockstep with each other.” The prescription drug managers then negotiate with the manufacturers to get a percentage of that price in exchange for prominently promoting their high-price insulin over cheaper alternatives.

“People are losing their lives because they can’t afford the drug,” Bonta said.

Daphne Dorsey, associate director for media relations for Eli Lilly, said the company is “disappointed by the California Attorney General’s false accusations.” She said the average monthly-out-of-pocket cost for Lilly insulin is $21.80, a 44% decrease over the past five years. She urged anyone paying more than $35 a month for Lilly insulin to contact the company.

A representative for Novo Nordisk declined to comment on the lawsuit. But the company provided background information saying the net prices for its insulin products — the list price minus rebates and discounts — have fallen in each of the past five years “in large part to the significant rebates and discounts manufacturers pay to ensure access for patients.”

Mike DeAngelis, executive director of corporate communications for CVS Health, said the manufacturers alone set the list price for their products.

“Nothing in our agreements prevents drug manufacturers from lowering the prices of their insulin products and we would welcome such action,” he said. “Allegations that we play any role in determining the prices charged by manufacturers are false. We plan to vigorously defend against this complaint.”

A statement from Optum Rx said the company “welcomes the opportunity to show the California Office of the Attorney General, just as it has with other States Attorneys General, how we work every day to provide people with access to affordable drugs, including insulin.”

Insulin is made by the pancreas and is used by the human body to convert the food we eat into energy. People who have diabetes don’t produce enough insulin. People with Type 1 diabetes must take insulin every day to survive.

A team of Canadian scientists discovered insulin a century ago. They sold the patent to the University of Toronto for just $1, hoping to avoid a monopoly that could cause high prices. But eventually, the market came to be dominated by just three companies.

Kevin Wren, an activist associated with the California chapter of #Insulin4All, said he must take insulin every day to survive. Around 2009, Wren said he was working two jobs and did not have health insurance. He had to ration his insulin, taking less than the recommended dosage to make it last longer — a dangerous practice that he said ended up putting him in the hospital with ketoacidosis, a serious complication of diabetes.

Today, Wren says he has good health insurance and doesn’t have to ration his supply of insulin. He said he skirts the law each month by providing people insulin from someone else’s prescription “all so that they don’t have to ration.”

The big insulin manufacturing companies have assistance programs to help people purchase insulin. Novo Nordisk said in 2021 that more than a million people used some form of the company’s assistance when purchasing its insulin.

California’s state government is considering making its own insulin and selling it at a much cheaper price. Last year, the state Legislature approved $100 million for the project, with $50 million set aside for developing three types of insulin and the rest going to a potential manufacturing facility.

State officials hope a California brand of generic insulin could disrupt the market and bring all insulin prices down. Bonta said he hopes his lawsuit does the same thing.

“California can drive markets,” Bonta said, citing the state’s size and economic power. “Change emanates and starts here.”

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

FILE - A sign is shown on a Google building at their campus in Mountain View, Calif., Sept. 24, 201...
Associated Press

Google hopes ‘Bard’ will outsmart ChatGPT, Microsoft in AI

Google is girding for a battle of wits in the field of artificial intelligence with “Bard," a conversational service apparently aimed at countering the popularity of the ChatGPT tool backed by Microsoft.
16 hours ago
FILE - A Boeing 737 Max jet prepares to land at Boeing Field following a test flight in Seattle, Se...
Associated Press

Boeing plans to cut about 2,000 finance and HR jobs in 2023

Boeing plans to make staffing cuts in the aerospace company's finance and human resources departments in 2023, with a loss of around 2,000 jobs
16 hours ago
(Jennifer Bakos via AP)...
Associated Press

1 missing, 2 rescued from crab boat off Washington coast

A crew member remains missing and two others were rescued from crab boat that sank near Willapa Bay in southwest Washington on Sunday evening, according to the Coast Guard.
16 hours ago
child marriages...
Associated Press

Proposed bill would pay incarcerated workers minimum wage

A Washington state lawmaker who has spent time in prison wants the state to pay incarcerated workers minimum wage for doing their jobs.
16 hours ago
Associated Press

Space Force vows ‘above and beyond’ cleanup of Maui spill

WAILUKU, Hawaii (AP) — The U.S. Space Force said a power surge during a lightning storm likely caused a mechanical issue that allowed about 700 gallons (2,750 liters) of diesel fuel to spill last week at the environmentally sensitive and culturally important summit of Haleakala mountain on Hawaii’s Maui Island, authorities said. Brig. Gen. Anthony […]
16 hours ago
Associated Press

Associate of Russian oligarch accused of violating sanctions

NEW YORK (AP) — An associate of a Russian billionaire was charged in an indictment unsealed Tuesday with violating U.S. sanctions and money laundering. The indictment charged Vladimir Voronchenko, a Russian who is a permanent U.S. resident, with joining a scheme to make over $4 million in payments to maintain four U.S. properties belonging to […]
16 hours ago

Sponsored Articles

safety from crime...

As crime increases, our safety measures must too

It's easy to be accused of fearmongering regarding crime, but Seattle residents might have good reason to be concerned for their safety.
Comcast Ready for Business Fund...
Ilona Lohrey | President and CEO, GSBA

GSBA is closing the disparity gap with Ready for Business Fund

GSBA, Comcast, and other partners are working to address disparities in access to financial resources with the Ready for Business fund.
SHIBA WA...

Medicare open enrollment is here and SHIBA can help!

The SHIBA program – part of the Office of the Insurance Commissioner – is ready to help with your Medicare open enrollment decisions.
Lake Washington Windows...

Choosing Best Windows for Your Home

Lake Washington Windows and Doors is a local window dealer offering the exclusive Leak Armor installation.
Anacortes Christmas Tree...

Come one, come all! Food, Drink, and Coastal Christmas – Anacortes has it all!

Come celebrate Anacortes’ 11th annual Bier on the Pier! Bier on the Pier takes place on October 7th and 8th and features local ciders, food trucks and live music - not to mention the beautiful views of the Guemes Channel and backdrop of downtown Anacortes.
Swedish Cyberknife Treatment...

The revolutionary treatment of Swedish CyberKnife provides better quality of life for majority of patients

There are a wide variety of treatments options available for men with prostate cancer. One of the most technologically advanced treatment options in the Pacific Northwest is Stereotactic Body Radiation Therapy using the CyberKnife platform at Swedish Medical Center.
California latest to sue drug companies over insulin prices